BioAge Labs, Inc. (BIOA): A Bull Case Theory

Yahoo FinanceApr 21 13:02 ET

AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."

① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.

cls.cnApr 11 07:59 ET

Several Insiders Invested In BioAge Labs Flagging Positive News

Yahoo FinanceMar 26 08:59 ET

Bioage Labs Is Maintained at Neutral by Citigroup

Dow JonesMar 24 10:51 ET · Ratings

Citigroup Maintains Neutral on Bioage Labs, Lowers Price Target to $5

BenzingaMar 24 10:41 ET · Ratings

Bioage Labs Analyst Ratings

BenzingaMar 24 10:40 ET · Ratings

IPO Roundup: CoreWeave, StubHub and More

Seeking AlphaMar 24 09:17 ET

Cautious Outlook on BioAge Labs Amid Promising Developments and High Risk

TipRanksMar 23 14:15 ET

BioAge Labs, Inc.: Sell Rating Due to Discontinued Program and Uncertain Prospects

TipRanksMar 23 14:15 ET · Ratings

Jefferies Downgrades BioAge Labs(BIOA.US) to Hold Rating, Cuts Target Price to $7

Moomoo NewsMar 21 22:31 ET · Ratings

William Blair Sticks to Its Hold Rating for BioAge Labs, Inc. (BIOA)

TipRanksMar 21 07:27 ET · Ratings

BioAge Labs | 10-K: FY2024 Annual Report

SECMar 20 17:05 ET · Announcements

BioAge Labs | 8-K: BioAge Labs Reports Full Year 2024 Financial Results and Provides Business Updates from the Fourth Quarter of 2024

SECMar 20 16:54 ET · Announcements

BioAge Labs FY24 EPS $(6.63) Up From $(38.17) YoY

BenzingaMar 20 16:33 ET

BioAge Labs: Existing Cash and Cash Equivalents Sufficient to Fund Ops and Cap Expenses Through 2029 >BIOA

Dow JonesMar 20 16:33 ET

BioAge Labs FY24 Loss $71.1M >BIOA

Dow JonesMar 20 16:33 ET

BioAge Labs FY24 Loss/Shr $6.63 >BIOA

Dow JonesMar 20 16:33 ET

Express News | Bioage Labs Reports Full Year 2024 Financial Results and Provides Business Updates From the Fourth Quarter of 2024

ReutersMar 20 16:30 ET

The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.

Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.

Zhitong FinanceMar 18 03:00 ET

Express News | Bioarctic Receives Orphan Drug Designation for Exidavnemab the US

ReutersMar 17 13:50 ET